Earnings Outlook For Dare Bioscience
Portfolio Pulse from Benzinga Insights
Dare Bioscience (NASDAQ:DARE) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.10. The company's past performance shows a mixed trend of EPS estimates and actuals, with the last quarter showing no difference between the two. The share price increased by 6.0% the day after the last earnings release. However, the stock has been down 61.06% over the last 52-week period.
November 08, 2023 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Dare Bioscience is expected to report an EPS of $-0.10 in its upcoming earnings. The stock has been down 61.06% over the last year, which may concern long-term shareholders.
The company's stock has been on a downward trend over the past year, which may concern investors. The upcoming earnings report, with an estimated EPS of $-0.10, may further impact the stock negatively if the company fails to meet or exceed this estimate.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100